Global Cancer Immunotherapy Drug Discovery Outsourcing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Cancer Immunotherapy Drug Discovery Outsourcing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Cancer Immunotherapy Drug Discovery Outsourcing market size is estimated to be worth US$ 1027.7 million in 2021 and is forecast to a readjusted size of USD 2031 million by 2028 with a CAGR of 10.2% during review period. Lung accounting for % of the Cancer Immunotherapy Drug Discovery Outsourcing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While By Drug Type segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cancer Immunotherapy Drug Discovery Outsourcing include Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd, Crown Bioscience, Inc., and DiscoverX Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Immunotherapy Drug Discovery Outsourcing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
By Drug Type
By Cancer Type
Market segment by Application, can be divided into
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
Market segment by players, this report covers
Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Immunotherapy Drug Discovery Outsourcing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Immunotherapy Drug Discovery Outsourcing, with revenue, gross margin and global market share of Cancer Immunotherapy Drug Discovery Outsourcing from 2019 to 2022.
Chapter 3, the Cancer Immunotherapy Drug Discovery Outsourcing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Immunotherapy Drug Discovery Outsourcing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Immunotherapy Drug Discovery Outsourcing research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cancer Immunotherapy Drug Discovery Outsourcing
1.2 Classification of Cancer Immunotherapy Drug Discovery Outsourcing by Type
1.2.1 Overview: Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type in 2021
1.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market by Application
1.3.1 Overview: Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head and Neck
1.3.8 Ovarian
1.3.9 Pancreatic
1.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size & Forecast
1.5 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast by Region
1.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region, (2017-2022)
1.5.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Prospect (2017-2028)
1.5.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Prospect (2017-2028)
1.5.6 South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
1.6.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
1.6.3 Cancer Immunotherapy Drug Discovery Outsourcing Trends Analysis
2 Company Profiles
2.1 Aquila BioMedical
2.1.1 Aquila BioMedical Details
2.1.2 Aquila BioMedical Major Business
2.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.1.4 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Aquila BioMedical Recent Developments and Future Plans
2.2 BPS Bioscience, Inc.
2.2.1 BPS Bioscience, Inc. Details
2.2.2 BPS Bioscience, Inc. Major Business
2.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.2.4 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 BPS Bioscience, Inc. Recent Developments and Future Plans
2.3 Celentyx Ltd
2.3.1 Celentyx Ltd Details
2.3.2 Celentyx Ltd Major Business
2.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.3.4 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Celentyx Ltd Recent Developments and Future Plans
2.4 Crown Bioscience, Inc.
2.4.1 Crown Bioscience, Inc. Details
2.4.2 Crown Bioscience, Inc. Major Business
2.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.4.4 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Crown Bioscience, Inc. Recent Developments and Future Plans
2.5 DiscoverX Corporation
2.5.1 DiscoverX Corporation Details
2.5.2 DiscoverX Corporation Major Business
2.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.5.4 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 DiscoverX Corporation Recent Developments and Future Plans
2.6 Explicyte
2.6.1 Explicyte Details
2.6.2 Explicyte Major Business
2.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.6.4 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Explicyte Recent Developments and Future Plans
2.7 Genscript Biotech Corporation
2.7.1 Genscript Biotech Corporation Details
2.7.2 Genscript Biotech Corporation Major Business
2.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.7.4 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Genscript Biotech Corporation Recent Developments and Future Plans
2.8 HD Biosciences Co.
2.8.1 HD Biosciences Co. Details
2.8.2 HD Biosciences Co. Major Business
2.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.8.4 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 HD Biosciences Co. Recent Developments and Future Plans
2.9 Horizon Discovery Group PLC
2.9.1 Horizon Discovery Group PLC Details
2.9.2 Horizon Discovery Group PLC Major Business
2.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.9.4 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Horizon Discovery Group PLC Recent Developments and Future Plans
2.10 ImmunXperts SA
2.10.1 ImmunXperts SA Details
2.10.2 ImmunXperts SA Major Business
2.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.10.4 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 ImmunXperts SA Recent Developments and Future Plans
2.11 Molecular Imaging, Inc.
2.11.1 Molecular Imaging, Inc. Details
2.11.2 Molecular Imaging, Inc. Major Business
2.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.11.4 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Molecular Imaging, Inc. Recent Developments and Future Plans
2.12 Promega Corporation,Personalis, Inc.
2.12.1 Promega Corporation,Personalis, Inc. Details
2.12.2 Promega Corporation,Personalis, Inc. Major Business
2.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.12.4 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Promega Corporation,Personalis, Inc. Recent Developments and Future Plans
2.13 STC Biologics
2.13.1 STC Biologics Details
2.13.2 STC Biologics Major Business
2.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
2.13.4 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 STC Biologics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share in 2021
3.2.2 Top 10 Cancer Immunotherapy Drug Discovery Outsourcing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Cancer Immunotherapy Drug Discovery Outsourcing Players Head Office, Products and Services Provided
3.4 Cancer Immunotherapy Drug Discovery Outsourcing Mergers & Acquisitions
3.5 Cancer Immunotherapy Drug Discovery Outsourcing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Market Share by Type (2017-2022)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application (2017-2022)
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2028)
6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2028)
6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
6.3.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2028)
6.3.2 United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
6.3.3 Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
6.3.4 Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2028)
7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2028)
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
7.3.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2028)
7.3.2 Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
7.3.3 France Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
7.3.5 Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
7.3.6 Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2028)
8.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2028)
8.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region
8.3.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Region (2017-2028)
8.3.2 China Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
8.3.3 Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
8.3.4 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
8.3.5 India Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
8.3.7 Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2028)
9.2 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2028)
9.3 South America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
9.3.1 South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2028)
9.3.2 Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
9.3.3 Argentina Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2028)
10.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2028)
10.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
10.3.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2028)
10.3.2 Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
10.3.4 UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Cancer Immunotherapy Drug Discovery Outsourcing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Region (2023-2028)
Table 6. Aquila BioMedical Corporate Information, Head Office, and Major Competitors
Table 7. Aquila BioMedical Major Business
Table 8. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 9. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. BPS Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. BPS Bioscience, Inc. Major Business
Table 12. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 13. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Celentyx Ltd Corporate Information, Head Office, and Major Competitors
Table 15. Celentyx Ltd Major Business
Table 16. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 17. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Crown Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Crown Bioscience, Inc. Major Business
Table 20. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 21. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. DiscoverX Corporation Corporate Information, Head Office, and Major Competitors
Table 23. DiscoverX Corporation Major Business
Table 24. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 25. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Explicyte Corporate Information, Head Office, and Major Competitors
Table 27. Explicyte Major Business
Table 28. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 29. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Genscript Biotech Corporation Corporate Information, Head Office, and Major Competitors
Table 31. Genscript Biotech Corporation Major Business
Table 32. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 33. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. HD Biosciences Co. Corporate Information, Head Office, and Major Competitors
Table 35. HD Biosciences Co. Major Business
Table 36. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 37. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Horizon Discovery Group PLC Corporate Information, Head Office, and Major Competitors
Table 39. Horizon Discovery Group PLC Major Business
Table 40. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 41. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. ImmunXperts SA Corporate Information, Head Office, and Major Competitors
Table 43. ImmunXperts SA Major Business
Table 44. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 45. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Molecular Imaging, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Molecular Imaging, Inc. Major Business
Table 48. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 49. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Promega Corporation,Personalis, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Promega Corporation,Personalis, Inc. Major Business
Table 52. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 53. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. STC Biologics Corporate Information, Head Office, and Major Competitors
Table 55. STC Biologics Major Business
Table 56. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product and Solutions
Table 57. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Cancer Immunotherapy Drug Discovery Outsourcing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Cancer Immunotherapy Drug Discovery Outsourcing Players Head Office, Products and Services Provided
Table 62. Cancer Immunotherapy Drug Discovery Outsourcing Mergers & Acquisitions in the Past Five Years
Table 63. Cancer Immunotherapy Drug Discovery Outsourcing New Entrants and Expansion Plans
Table 64. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) by Type (2017-2022)
Table 65. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Type (2017-2022)
Table 66. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Forecast by Type (2023-2028)
Table 67. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2022)
Table 68. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Forecast by Application (2023-2028)
Table 69. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Cancer Immunotherapy Drug Discovery Outsourcing Picture
Figure 2. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type in 2021
Figure 3. Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Application in 2021
Figure 4. Lung Picture
Figure 5. Breast Picture
Figure 6. Colorectal Picture
Figure 7. Melanoma Picture
Figure 8. Prostate Picture
Figure 9. Head and Neck Picture
Figure 10. Ovarian Picture
Figure 11. Pancreatic Picture
Figure 12. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Region (2017-2028)
Figure 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Region in 2021
Figure 16. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
Figure 22. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
Figure 23. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends
Figure 24. Aquila BioMedical Recent Developments and Future Plans
Figure 25. BPS Bioscience, Inc. Recent Developments and Future Plans
Figure 26. Celentyx Ltd Recent Developments and Future Plans
Figure 27. Crown Bioscience, Inc. Recent Developments and Future Plans
Figure 28. DiscoverX Corporation Recent Developments and Future Plans
Figure 29. Explicyte Recent Developments and Future Plans
Figure 30. Genscript Biotech Corporation Recent Developments and Future Plans
Figure 31. HD Biosciences Co. Recent Developments and Future Plans
Figure 32. Horizon Discovery Group PLC Recent Developments and Future Plans
Figure 33. ImmunXperts SA Recent Developments and Future Plans
Figure 34. Molecular Imaging, Inc. Recent Developments and Future Plans
Figure 35. Promega Corporation,Personalis, Inc. Recent Developments and Future Plans
Figure 36. STC Biologics Recent Developments and Future Plans
Figure 37. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Players in 2021
Figure 38. Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share in 2021
Figure 40. Global Top 10 Players Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Type in 2021
Figure 43. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Forecast by Type (2023-2028)
Figure 44. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application in 2021
Figure 45. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Forecast by Application (2023-2028)
Figure 46. North America Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Type (2017-2028)
Figure 47. North America Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Application (2017-2028)
Figure 48. North America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Country (2017-2028)
Figure 49. United States Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Type (2017-2028)
Figure 53. Europe Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Application (2017-2028)
Figure 54. Europe Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Country (2017-2028)
Figure 55. Germany Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Region (2017-2028)
Figure 63. China Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Type (2017-2028)
Figure 70. South America Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Application (2017-2028)
Figure 71. South America Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Cancer Immunotherapy Drug Discovery Outsourcing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
